WL Suarez-Pinzon, GS Cembrowski, A … - Diabetologia, 2009 - Springer Page 1. RESEARCH LETTER Combination therapy with a dipeptidyl peptidase-4
inhibitor and a proton pump inhibitor restores normoglycaemia ... Related articles - All 2 versions
F Greco, MJ Vicent - Advanced Drug Delivery Reviews, 2009 - Elsevier The discovery of new molecular targets and the subsequent development of novel
anticancer agents are opening new possibilities for drug combination therapy as
anticancer treatment. Polymer–drug conjugates are well established for ... Related articles - All 2 versions
MJ Riedel, DF Gaddy, A Asadi, PD Robbins, TJ … - Gene Therapy, 2009 - nature.com Glucagon-like peptide-1 (GLP-1) is an incretin hormone that performs a wide
array of well-characterized antidiabetic actions, including stimulation of
glucose-dependent insulin secretion, upregulation of insulin gene ...
F Fallarino, G Luca, M Calvitti, F Mancuso, C … - Journal of Experimental Medicine, 2009 - jem.rupress.org Type I diabetes mellitus is caused by autoimmune destruction of pancreatic β
cells, and effective treatment of the disease might require rescuing β cell
function in a context of reinstalled immune tolerance. Sertoli cells (SCs) ... Related articles - All 3 versions